Massachusetts Pharmacists Association

09/09/2025

https://www.heart.org/en/health-topics/high-blood-pressure/the-facts-about-high-blood-pressure/high-bp-top-10

09/08/2025

The 2025 AHA/ACC High Blood Pressure Guideline reflects the latest recommendations and advancements in hypertension research and clinical practice. https://newsroom.heart.org/news/new-high-blood-pressure-guideline-emphasizes-prevention-early-treatment-to-reduce-cvd-risk

09/07/2025

09/06/2025

The FDA approved fremanezumab-vfrm (Ajovy) for the preventative treatment of episodic migraine for patients aged 6 to 17 years who weigh 45 kg or more. This marks the first approval for a calcitonin gene-related peptide antagonist for the prevention of episodic migraine for pediatric and adult patients. https://ir.tevapharm.com/news-and-events/press-releases/press-release-details/2025/FDA-Approves-Expanded-Indication-for-AJOVY-fremanezumab-vfrm-The-First-Anti-CGRP-Preventive-Treatment-for-Pediatric-Episodic-Migraine/default.aspx

09/05/2025

https://masspharmacists.org/content.aspx?page_id=4091&club_id=131603&item_id=2701055

09/04/2025

https://www.facebook.com/share/1FNnqVUyX1/

Massachusetts Gov. Maura Healey announced the state will be taking measures to ensure vaccines remain accessible to everyone.

09/03/2025

Breaking News

https://www.mass.gov/news/standing-order-for-dispensing-and-administration-of-covid-2025-2026?fbclid=IwVERDUAMlaKVleHRuA2FlbQIxMAABHkwtD2Y10Dr71GThbxNbklHsNn5XmtxHqaY-wg1jfRQ5-7a5UFjMgV4zgmqc_aem_7d4cLaJ0yahgC70WESaU6g

A lock icon ( ) or https:// means you’ve safely connected to the official website. Share sensitive information only on official, secure websites.

09/02/2025

The use of sulfonylureas to treat type 2 diabetes has decreased from 30.7% (2010) to 12.9% (2020), but the drug class is still commonly used. Now, a new study suggests that the leading drug in that class, glipizide, is linked to a higher incidence of heart failure, related hospitalization, and death compared with dipeptidyl peptidase-4 inhibitors https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2836782